Hierarchical Linear Models for Multiregional Clinical Trials

被引:6
|
作者
Kim, Saemina [1 ]
Kang, Seung-Ho [1 ]
机构
[1] Yonsei Univ, Dept Appl Stat, 262 Seongsanno, Seoul 120749, South Korea
来源
基金
新加坡国家研究基金会;
关键词
Between-cluster variability; Mixed effect model; Permutation test; Random coefficient model; SAMPLE-SIZE; CONSISTENCY ASSESSMENT; JAPANESE PATIENTS; DESIGN; REGIONS;
D O I
10.1080/19466315.2019.1654914
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data observed in multiregional clinical trials are structurally hierarchical in the sense that the patient population consists of several regions and patients are nested within their own regions. To reflect such hierarchical structure, in this article, we propose two-level hierarchical linear models in which the level-1 model is based on patient-level data such as treatment indicator and age, and the level-2 model is based on region-level data such as medical practices. The fixed effect model and the continuous random effect model are shown to be special cases of hierarchical linear models. We conducted simulation studies to investigate the empirical Type I error rates of three methods for testing the overall treatment effect. The performance of the testing method with sample ratios as weights and the empirical Bayes estimator for between-region variability is better than that of the other two testing methods.
引用
收藏
页码:334 / 343
页数:10
相关论文
共 50 条
  • [31] Interpreting hierarchical linear and hierarchical generalized linear models with slopes as outcomes
    Tate, R
    [J]. JOURNAL OF EXPERIMENTAL EDUCATION, 2004, 73 (01): : 71 - 95
  • [32] Use of interval estimations in design and evaluation of multiregional clinical trials with continuous outcomes
    Chiang, Chieh
    Hsiao, Chin-Fu
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2019, 28 (07) : 2179 - 2195
  • [33] Results of a Survey of PhRMA Member Companies on Practices Associated with Multiregional Clinical Trials
    Nick Scott
    Bruce Binkowitz
    Ekopimo Okon Ibia
    Tonya Houck
    Belinda Field
    Steven D. Talerico
    Yoko Tanaka
    Andy Lee
    [J]. Drug information journal : DIJ / Drug Information Association, 2011, 45 : 609 - 617
  • [34] Approximate reduction of linear population models governed by stochastic differential equations: application to multiregional models
    Sanz, Luis
    Alonso, Juan Antonio
    [J]. JOURNAL OF BIOLOGICAL DYNAMICS, 2017, 11 (01) : 461 - 479
  • [35] Cautionary note on regional consistency evaluation in multiregional clinical trials with binary outcomes
    Homma, Gosuke
    [J]. PHARMACEUTICAL STATISTICS, 2024, 23 (03) : 385 - 398
  • [36] Results of a Survey of PhRMA Member Companies on Practices Associated With Multiregional Clinical Trials
    Scott, Nick
    Binkowitz, Bruce
    Ibia, Ekopimo Okon
    Houck, Tanya
    Field, Belinda
    Talerico, Steven D.
    Tanaka, Yoko
    Lee, Andy
    [J]. DRUG INFORMATION JOURNAL, 2011, 45 (05): : 609 - 617
  • [37] DESIGN AND ANALYSIS ISSUES OF MULTIREGIONAL CLINICAL TRIALS WITH DIFFERENT REGIONAL PRIMARY ENDPOINTS
    Tsou, Hsiao-Hui
    Tsong, Yi
    Chang, Wan-Jung
    Dong, Xiaoyu
    Hsiao, Chin-Fu
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2012, 22 (05) : 1051 - 1059
  • [38] Sample Size Estimation of Multiregional Clinical Trials with Heterogeneous Variability Across Regions
    Wu, Yuh-Jenn
    Tan, Te-Sheng
    Chow, Shein-Chung
    Hsiao, Chin-Fu
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (02) : 254 - 271
  • [39] An empirical Bayes approach to evaluation of results for a specific region in multiregional clinical trials
    Huang, Yufen
    Chang, Wan-Jung
    Hsiao, Chin-Fu
    [J]. PHARMACEUTICAL STATISTICS, 2013, 12 (02) : 59 - 64
  • [40] Factors Associated with Inclusion of Japan in Phase I Multiregional Clinical Trials in Oncology
    Maki, Akio
    Narukawa, Mamoru
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (04) : 766 - 772